Blueprint Medicines Corporation (0HOJ.L)

USD 101.7

(4.02%)

Eps Summary of Blueprint Medicines Corporation

  • Blueprint Medicines Corporation's latest annual eps in 2023 was -8.37 USD , up 10.48% from previous year.
  • Blueprint Medicines Corporation's latest quarterly eps in 2024 Q3 was -0.89 USD , down -11.25% from previous quarter.
  • Blueprint Medicines Corporation reported an annual eps of -9.35 USD in 2022, up 15.08% from previous year.
  • Blueprint Medicines Corporation reported an annual eps of -11.01 USD in 2021, down -291.15% from previous year.
  • Blueprint Medicines Corporation reported a quarterly eps of 1.45 USD for 2024 Q1, up 179.67% from previous quarter.
  • Blueprint Medicines Corporation reported a quarterly eps of -0.80 USD for 2024 Q2, down -155.17% from previous quarter.

Annual Eps Chart of Blueprint Medicines Corporation (2023 - 2013)

Historical Annual Eps of Blueprint Medicines Corporation (2023 - 2013)

Year Eps Eps Growth
2023 -8.37 USD 10.48%
2022 -9.35 USD 15.08%
2021 -11.01 USD -291.15%
2020 5.76 USD 183.84%
2019 -6.87 USD -27.46%
2018 -5.39 USD -37.5%
2017 -3.92 USD -48.48%
2016 -2.64 USD 8.65%
2015 -2.89 USD 6.17%
2014 -3.08 USD -92.5%
2013 -1.60 USD 0.0%

Peer Eps Comparison of Blueprint Medicines Corporation

Name Eps Eps Difference
uniQure N.V. -6.47 USD -29.366%
Abeona Therapeutics Inc. -2.53 USD -230.83%
Aclaris Therapeutics, Inc. -1.27 USD -559.055%
Agios Pharmaceuticals, Inc. -6.33 USD -32.227%
Atara Biotherapeutics, Inc. -65.18 USD 87.159%
Cara Therapeutics, Inc. -2.19 USD -282.192%
Imunon, Inc. -2.16 USD -287.5%
Dynavax Technologies Corporation -0.05 USD -16775.0%
Editas Medicine, Inc. -2.02 USD -314.356%
FibroGen, Inc. -2.92 USD -186.644%
Iovance Biotherapeutics, Inc. -1.89 USD -342.857%
Kala Pharmaceuticals, Inc. -17.35 USD 51.758%
Neurocrine Biosciences, Inc. 2.56 USD 426.953%
Sarepta Therapeutics, Inc. -5.80 USD -44.31%
Supernus Pharmaceuticals, Inc. 0.02 USD 34830.29%
Verastem, Inc. -3.96 USD -111.364%
Zoetis Inc. 5.08 USD 264.764%
Vertex Pharmaceuticals Incorporated 14.05 USD 159.573%
Sangamo Therapeutics, Inc. -1.48 USD -465.541%
Homology Medicines, Inc. -7.41 USD -12.955%
Nektar Therapeutics -1.45 USD -477.241%
Viking Therapeutics, Inc. -0.91 USD -819.78%
Unity Biotechnology, Inc. -2.70 USD -210.0%
Perrigo Company plc -0.09 USD -8813.738%
Esperion Therapeutics, Inc. -2.03 USD -312.315%
Walgreens Boots Alliance, Inc. -10.01 USD 16.384%
Illumina, Inc. -7.35 USD -13.878%
Thermo Fisher Scientific Inc. 15.53 USD 153.896%
IQVIA Holdings Inc. 7.39 USD 213.261%
Heron Therapeutics, Inc. -0.80 USD -946.25%
Waters Corporation 10.87 USD 177.001%
Biogen Inc. 8.02 USD 204.364%
Evolus, Inc. -1.08 USD -675.0%
Adicet Bio, Inc. -3.31 USD -152.87%
bluebird bio, Inc. -1.93 USD -333.679%
Geron Corporation -0.32 USD -2515.625%
Alnylam Pharmaceuticals, Inc. -3.52 USD -137.784%
Amicus Therapeutics, Inc. -0.51 USD -1541.176%
Myriad Genetics, Inc. -1.39 USD -502.158%
Intellia Therapeutics, Inc. -5.42 USD -54.428%
Mettler-Toledo International Inc. 36.10 USD 123.186%
Corbus Pharmaceuticals Holdings, Inc. -10.31 USD 18.817%
BioMarin Pharmaceutical Inc. 0.89 USD 1040.449%
Regeneron Pharmaceuticals, Inc. 37.05 USD 122.591%
Agilent Technologies, Inc. 4.22 USD 298.341%
OPKO Health, Inc. -0.25 USD -3248.0%
Exelixis, Inc. 0.65 USD 1387.692%
Corcept Therapeutics Incorporated 1.02 USD 920.588%
Anavex Life Sciences Corp. -0.60 USD -1295.0%
Axsome Therapeutics, Inc. -5.27 USD -58.824%
Ionis Pharmaceuticals, Inc. -2.56 USD -226.953%
Halozyme Therapeutics, Inc. 2.13 USD 492.958%
Insmed Incorporated -5.34 USD -56.742%
TG Therapeutics, Inc. 0.09 USD 9472.9%
Incyte Corporation 2.67 USD 413.483%
Emergent BioSolutions Inc. -14.85 USD 43.636%